NCT04229433View on ClinicalTrials.gov

The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

November 8, 2020

Study Completion Date

November 8, 2020

Conditions
Thrombus
Interventions
DRUG

SHR2285 tablet

Pharmaceutical form: SHR2285 tablet Route of administration: single dose and multiple doses.

DRUG

Placebo

Pharmaceutical form: Placebo tablet Route of administration: single dose and multiple doses.

Trial Locations (1)

310014

Zhejing Provincial People's Hospital, Hangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04229433 - The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter